siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions (Q39437920)

12 September 2017

title

siRNA-mediated silencing of PD-1 ligands enhances tumor-specific human T-cell effector functions (English)

1 reference

12 September 2017

K Iwamura

1

1 reference

12 September 2017

T Kato

2

1 reference

12 September 2017

Y Miyahara

3

1 reference

12 September 2017

H Naota

4

1 reference

12 September 2017

J Mineno

5

1 reference

12 September 2017

H Ikeda

6

1 reference

12 September 2017

H Shiku

7

1 reference

12 September 2017

publication date

24 November 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

19

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

959-966

1 reference

Adoptive T cell therapy for cancer in the clinic

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Cancer despite immunosurveillance: immunoselection and immunosubversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Adoptive immunotherapy for cancer: building on success

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Negative co-receptors on lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

New regulatory co-receptors: inducible co-stimulator and PD-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Inhibitory B7-family molecules in the tumour microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

PD-1 and its ligands in tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Cross-linking of B7-H1 on EBV-transformed B cells induces apoptosis through reactive oxygen species production, JNK signaling activation, and fasL expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Transfer of specificity by murine alpha and beta T-cell receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

T cell receptor gene therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Gene transfer approaches in cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Determination of cellularly processed HLA-A2402-restricted novel CTL epitopes derived from two cancer germ line genes, MAGE-A4 and SAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Long-term phenotypic, functional and genetic stability of cancer-specific T-cell receptor (TCR) alphabeta genes transduced to CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

B7-H1 expression on old CD8+ T cells negatively regulates the activation of immune responses in aged animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

PDZ Domain Proteins: Plug and Play!

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

RNA interference targeting programmed death receptor-1 improves immune functions of tumor-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Myeloid-derived suppressor cells: linking inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Generation of peptide-specific CD8+ T cells by phytohemagglutinin-stimulated antigen-mRNA-transduced CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

7 January 2021

Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

7 January 2021

PD-L2 is expressed on activated human T cells and regulates their function

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

7 January 2021

Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.185

7 January 2021

https://api.crossref.org/works/10.1038%2FGT.2011.185

1 reference

7 January 2021

Identifiers

DOI

10.1038/GT.2011.185

1 reference

12 September 2017

1 reference